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Background: In 2009, the Belgian National Institute of Health and Disability Insurance established a care trajectory (CT)
for a subgroup of type 2 diabetes mellitus patients (T2DM) based on Wagner’s chronic care model. The goal of this CT
is to optimise the quality of care using an integrated multidisciplinary approach. This study aims to identify patient-
related factors associated with inclusion in a CT and to determine the most frequent reasons for non-inclusion.
Methods: In 2010, the Belgian Sentinel Network of General Practices conducted a prevalence study of type 2 diabetes.
The surveillance study carried out by this nationwide, representative network collected unique information about
eligibility for the CT, inclusion in the CT and reasons for non-inclusion.
Based on the official inclusion and exclusion criteria, we first identified a group of eligible patients. Within this group,
we then calculated the proportion of patients included in a CT as well as the prevalence of reasons for non-inclusion as
reported by GPs. Furthermore, bivariate associations between patient-level parameters and inclusion were analysed.
Finally, any patient-level parameters found to be statistically significant were included in a multivariate logistic
regression model.
Results: The 2010 study recorded 4600 Belgian type 2 diabetes patients. According to the official criteria, 589 patients
were eligible for inclusion in a CT T2DM. By the end of August 2011, 95 patients had been included in a CT T2DM.
Our findings reveal that the younger the eligible patient was, the more likely he or she was to be included in a CT.
Patients living in Flanders were more likely to be included in the CT than were patients living in Wallonia. Motivated
patients with specific plans to change their diets were also more likely to be included in a CT.
The two most frequently reported reasons for non-inclusion were participation in another diabetes care programme
and the timing of this surveillance study (inclusion will take place in the near future).
Conclusions: Eligible diabetes patients who were admitted to a CT T2DM during the early phases of CT
implementation were mainly found to be those who are able to make progress in their disease trajectories. In the
future, more attention could be paid to also include more high-risk patients.
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As a result of higher life expectancies, the prevalence of
chronic diseases is increasing. The management of chronic
diseases poses an enormous challenge to our health care
system [1]. More than a decade ago, Wagner developed
a chronic care model, which aimed to ameliorate the
quality of chronic illness management within primary* Correspondence: katrien.vanthomme@gmail.com
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article, unless otherwise stated.care. According to this model, the improvement of six in-
terrelated components (i.e. self-management support, clin-
ical information systems, delivery system redesign, decision
support, health care organisation and community re-
sources) should lead to interaction between informed, ac-
tivated patients and prepared, proactive practice teams [2].
In 2009, the National Institute of Health and Disability
Insurance (NIHDI) in Belgium introduced care trajectories
(CT) for type 2 diabetes mellitus (T2DM) and chronic kid-
ney disease based on this chronic care model. The aims of
these CTs are to organise, coordinate and plan patientntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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tween patients, GPs, specialists and other caregivers; and
to optimise the quality of care [3]. During the first CT
phase, collaboration among patients, GPs and specialists is
formalised in a four-year contract. The benefits of a CT for
patients include receiving high quality care by means of a
personal care plan; having access to information, materials
and consultations; and receiving financial benefits. GPs
play a coordinating role in the CT, supported by local
multidisciplinary networks (LMNs) set up for this purpose.
This paper addresses the CT T2DM. Subgroups of
T2DM patients are eligible for a CT when they meet spe-
cific inclusion criteria, namely when they are on one or
two insulin injections a day or when they are insufficiently
regulated with a maximum dose of oral antidiabetics. At
the start of the CT, the following patients are excluded:
pregnant women and women hoping to become pregnant
soon; patients with type 1 diabetes; patients incapable of
visiting the GP’s practice; and patients living in a rest
home [3].
This study took place during the early phases of CT
T2DM implementation. The goals of the study were to
estimate the proportion of Belgian T2DM patients eli-
gible for the CT, the number of eligible patients who
had already been included at this early stage of CT im-
plementation and the reasons behind non-inclusion.
Gathering and analysing such information is crucial to
the evaluation of this new approach to chronic care
management, not only in Belgium but also internation-
ally since the exchange of expertise in this new domain
is essential [4]. Especially the study of the accessibility is
important since every chronic patient should have an
equal chance to be monitored well.
In particular, the research questions assessed in this
paper are:
1. What proportion of T2DM patients are eligible for a
CT based on the official inclusion and exclusion criteria?
2. What proportion of eligible patients had already been
included in a CT T2DM by the end of this survey?
3. If a patient was eligible but had not been included,
what reasons were reported by the GP for this
non-inclusion?
4. Which patient-related factors are associated with
inclusion in the CT T2DM?
Data and methods
Data collection
In 2010, a prevalence study of type 2 diabetes was con-
ducted by the Belgian Sentinel Network of General Prac-
tices (SGP). This nationwide surveillance system was
developed more than 30 years ago in line with similar
sentinel networks in Europe that have a low turnover
rate and voluntary participation. It has proven to be areliable surveillance system for a wide range of health-
related data, including diabetes [5-7]. The sentinel net-
work is distributed well across the various districts of
Belgium and was found to cover 1.5% (165,008 patients)
of the Belgian population in 2010. The age and sex dis-
tribution of the sentinel GPs is also representative of the
total Belgian GP population [8].
The SGP study included all patients diagnosed with type
2 diabetes before 2010. During the first phase of the study,
GPs were asked to group together their T2DM patients,
recording only the first contact with each patient in 2010
in order to avoid patients being recorded twice. In this
way, the prevalence of type 2 diabetes could be estimated.
Patients aged under 40 years were considered to be type 1
diabetes patients, and were therefore excluded. During this
first phase, the following parameters were recorded for all
T2DM patients: a patient identifier attributed by the GP,
age, sex, year of diagnosis, treatment (only diet, oral anti-
diabetics or insulin), smoking status and physical activity.
The second phase of the study was implemented one
month after the baseline data collection. In this phase,
the GPs were asked to fill in any missing parameters
from the first phase and to provide additional informa-
tion about their perceptions of the patients’ motivation
to improve their diet and stop smoking.
The third phase of the study took place in autumn 2011.
Based on the information available on the patients’ treat-
ment (i.e. the official inclusion criteria for the CT), the
group of T2DM patients eligible for inclusion in a CT was
defined. The GPs were asked to provide supplementary
data on the eligible patients related to the following pa-
rameters: current treatment (extended to include treat-
ment combinations and the category ‘incretin mimetics’),
consultation at the GP’s practice, inclusion in a CT, inclu-
sion date, reasons for non-inclusion (sometimes with the
option to add additional reasons), up-to-date LDL choles-
terol and height measurements, and the three most recent
weight, blood pressure and HbA1c values.Methods
The total type 2 diabetes population was our starting point
in answering the first research question on the proportion
of diabetics eligible for a CT. Based on the treatment data
gathered during the first phase of the surveillance study,
we identified a group of patients who met the official
inclusion and exclusion criteria (see Background section,
paragraph 3) and were therefore eligible for the CT
T2DM. We then used this group of eligible patients to
calculate the proportion already included in a CT at the
end of the surveillance survey in order to answer the sec-
ond research question.
To answer the third research question on the reasons
given by the GP behind the non-inclusion, eligible patients
Table 1 Reasons given by the Sentinel GPs for
non-inclusion of eligible patients in the early phase of the
Belgian diabetes type 2 care trajectory (August 2011)
N % (95% CI)
Patient is included in diabetes convention 179 49 (44-54)
Patient will be included in the near future 63 17 (14-21)
Inclusion not necessary according to the GP 28 8 (5-11)
Patient is not compliant, motivated 27 7 (5-11)
Other reasons 18 5 (3-8)
Patient will not sign the contract 17 5 (3-7)
GP will not sign the contract 17 5 (3-7)
Patient is included in the restricted programme
for glycaemic control
13 4 (2-6)
Patient does not want to consult a specialist 7 2 (1-4)
Too much administrative work 6 2 (1-4)
Patient lives (partially) abroad 5 1 (1-3)
Specialist will not sign the contract 4 1 (0-3)
Information for 366 of the 494 eligible patients not included in a CT.
Categories are not mutually exclusive.
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reasons for non-inclusion were categorised and measured
for prevalence, and 95% confidence intervals (95% CI) were
then calculated. GPs had been allowed to provide several
reasons per patient, so the categories were not treated as
mutually exclusive.
Finally, to answer the fourth research question on
patient-related factors associated with inclusion in the CT,
we examined the association of each relevant patient-level
parameter (age, sex, region, duration since diagnosis,
smoking status, physical activity, motivation to change diet
and the most recent values attained for the clinical param-
eters) to the dichotomous outcome parameter (inclusion
in a CT). Bivariate analysis was performed by means of chi
square tests (or Fisher exact if N of the lowest cell <10) for
the categorical variables and t-tests for the continuous var-
iables. Furthermore, the percentage of patients included in
a CT (+95% CI) was calculated for each category of the
patient-level parameters. Finally, all variables which were
found to have a significant (p < 0.05) bivariate association
with the outcome were all at once included in a logistic
multivariate model. Age and sex were included in the
model by default. We also tested a multilevel model that
included the patient-related variables nested in two levels,
being the GP as one level nested within a local multidis-
ciplinary network as an additional higher level. However,
this multilevel did not produce a better data fit than the
multivariate model and was therefore withdrawn.
Results
What proportion of T2DM patients were eligible for a CT
based on the official inclusion and exclusion criteria?
In 2010, 4600 Belgian type 2 diabetes patients were re-
corded. Based on the inclusion criteria described above,
674 patients were eligible for inclusion in a CT T2DM.
Of these 674 patients, 85 patients were excluded on the
basis of the following exclusion criteria: desire to be-
come pregnant (n = 1); living in a rest home (n = 15); in-
capable of visiting the GP’s practice (n = 65); and the
combination of living in a rest home and being incapable
of visiting the GP (n = 4). The final number of patients
eligible for a CT T2DM was 589 (13% [95% CI: 12-14]).
What proportion of eligible patients had already been
included in a CT T2DM?
By the end of the surveillance study in August 2011, 95
of all eligible patients had been included in a CT T2DM
(16% [95% CI: 13-19]).
What reasons were reported by GPs for the non-inclusion
of eligible patients?
Table 1 shows the main reasons given by GPs for the
non-inclusion of eligible patients in a CT. In more than
half of all cases, the patient was not included in the CTbecause he or she had already been admitted to an exist-
ing diabetes care programme (diabetes convention or
the restricted programme for glycaemic control). Ac-
cording to GPs, 17% of the non-included eligible pa-
tients were to be admitted to a CT in the near future. In
15% of cases, GPs reported that inclusion was not desir-
able and/or that the patient was not motivated enough
to be included in a CT.
What patient-related factors are associated with inclusion
in the CT T2DM?
Table 2 shows the results of the bivariate and multivari-
ate analyses. In Flanders, one in four eligible patients
were included in a CT T2DM. This was a significantly
higher percentage than in Wallonia, where only 6% of
eligible patients were included. Motivated patients with
specific plans to improve their diet were more often in-
cluded in a CT (23%) than less motivated patients. Al-
most one in three patients whose most recent HbA1c
values were well balanced were included in a CT. This
was a significantly higher percentage of inclusion com-
pared to patients whose HbA1c results were 7% or over.
In the multivariate model, all of the above-mentioned
associations remained statistically significant. Patients
living in Wallonia were less likely to be included in a CT
than patients living in Flanders; patients who had made
specific plans to improve their diet were more likely to
be included in a CT than patients who were motivated
to improve their diet but had not yet made specific
plans; patients with elevated HbA1c values were less
likely to be included in a CT. This model also revealed
that the older the patient was, the lower their odds of
being included in a CT T2DM.
Table 2 Patient-related factors associated with inclusion in the early phase of the Belgian diabetes type 2 care
trajectory
Bivariate Multivariate*
Mean (95% CI) p-value OR p-value
Age 68 (65-70) ns 0.96 0.016
Diabetes duration in years 12 (10-13) ns - -
% (95% CI) p-value
(Men) 15 (11-19)
Women 17 (14-22) ns 1.62 ns
(Flanders) 24 (19-28)
Wallonia 6 (3-9) 0.000 0.17 0.000
Brussels 15 (7-28) 0.47 ns
(Never smoked) 16 (12-20)
Quit smoking 17 (13-23) ns - -
Smoker 16 (9-26) - -
(Insufficient physical activity) 14 (11-19)
Sufficient physical activity 18 (14-22) ns - -
(Specific plans to change diet) 23 (17-29)
Motivated to change diet but no plans yet 12 (7-21) 0.035 0.35 0.007
No plans to change diet 14 (9-20) 0.55 ns
(Most recent BMI < 25 kg/m2) 14 (7-26)
Most recent BMI≥ 25 kg/m2 27 (22-32) ns - -
(Most recent blood pressure≤ 130/80 mmHg) 23 (18-30)
Most recent blood pressure > 130/80 mmHg 22 (17-28) ns - -
(Most recent HbA1c < 7.0%) 30 (22-39)
Most recent HbA1c≥ 7.0% 20 (15-25) 0.022 0.50 0.027
(Most recent LDL cholesterol≥ 100 mg/dl) 23 (17-30)
Most recent LDL cholesterol < 100 mg/dl 23 (18-29) ns - -
(Reference category).
ns = not significant.
CI: Confidence Intervals.
*N = eligible population. Due to missing values: age (n = 4), diet (n = 136), HbA1c (n = 178): N multivariate model: 327.
-: not included in multivariate model.
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At the end of this surveillance study, in August 2011, we
found that 16% of all eligible patients had been included
in a CT. This percentage initially appears low, but should
be seen in perspective. One important issue is the timing
of this study. As the CT T2DM started on 1 September
2009, the 2010 study could reflect only the situation in the
early phases of CT implementation. The timing issue was
also reflected in the non-inclusion reasons given by GPs,
where it was noticed that 17% of non-included eligible
cases would be included in the near future. Furthermore,
the official NIHDI figures, show that a considerable num-
ber of diabetes patients had already been included in a CT
T2DM during this early phase of CT implementation [4].
Additionally, more than half of the non-included eligible
patients had already been admitted to a different dia-
betes care programme. We can assume that if patientsare managing well on an existing diabetes care programme,
they will be less motivated to switch to the CT. Neverthe-
less, there are major differences between the two pro-
grammes; in that GPs play a far more central role in the
CT and also that the CT takes a more multidisciplinary,
patient-centred approach. Data from the Intermutualistic
Agency which consists of administrative and reimburse-
ment data of all sickness funds in Belgium, show that 28%
of CT patients had made the transition from the diabetes
convention to the CT [9]. In addition, the CT has already
covered more patients than the long-standing diabetes
convention category 3A.
Another important remark is that the CT’s exclusion
criteria have changed since our study was conducted.
Patients who are incapable of visiting a GP and those
living in rest homes are no longer denied access to a
CT. This makes the CT more accessible to patients who
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disease. The adaptation of the exclusion criteria and the
early timing of the study are two issues that may make it
desirable to repeat the surveillance study at a later stage.
Since the CT T2DM was introduced to improve the
quality of care for diabetes patients [2], it is important that
all eligible type 2 diabetes patients have equal chances of
being included. Yet, due to the study setting, we did not
have any information on social determinants. It would be
however interesting to study the association between so-
cial determinants and inclusion as is it likely that the so-
cially most vulnerable patients are excluded the most.
However, in our study we observed that younger patients,
patients living in Flanders (vs. patients living in Wallonia),
patients motivated to change their diet and patients with
better HbA1c values were more likely to be included in a
CT. The positive influence of a younger age and better
motivation could be explained by the fact that GPs are
more likely to include patients who are certain to make
progress in their disease trajectory. It is inherent to the
CT approach that patients need to make an effort to ob-
tain a healthier lifestyle by means of their personal care
plans. Lack of patient motivation was also one of the rea-
sons given by GPs for non-inclusion. Results from the
German disease management programme for diabetes also
reveal that patients who have a lower risk of diabetes
complications, higher self-activity rates and higher GP-
rated motivation were more likely to be included in the
programme [10]. This implies that in later stages of the
CT, more attention could also be paid to less ‘obvious’
groups for inclusion.
However, the regional CT inclusion discrepancy is more
closely related to structural issues. In our data, we ob-
served that Flemish GPs are more likely to include their
patients in a CT, whereas Walloon GPs are more likely to
enrol their diabetes patients on a different diabetes care
programme (i.e. the diabetes convention). These differ-
ences can also be observed in the real numbers of the
NIHDI [9], which proves that our data are reliable. It is
generally observed that differences exist between the ap-
proaches adopted by Flemish and Walloon GPs, and this
is a fact that is also reflected in our annual GP surveys [8].
The key strength of this SGP surveillance study on the
prevalence of diabetes lies in the fact that we were able
to determine the percentage of patients eligible for a CT
T2DM, the percentage already included in a CT T2DM
and the reasons given by the GP for non-inclusion. This
is unique information that is not available in electronic
health records or elsewhere. It has been shown previ-
ously that the SGP is representative of Belgian GPs as a
whole, which means that this study provides valid data
about the early phase of CT implementation [11]. As
mentioned above, it would be advisable to monitor these
data on a regular basis in order to track any changesover time, which is crucial information for policy-makers.
This kind of research is also indispensable for other coun-
tries implementing the chronic care model in their health
care management systems, as little research has been con-
ducted to date on such care programmes’ accessibility. A
lesson for the future and for other countries as well could
be to pay more attention to the inclusion of high-risk pa-
tients that are already in a later stage of their disease.
Conclusions
Eligible diabetes patients who had already been included
in a CT T2DM in the early phases of CT implementa-
tion were mainly those thought to be able to make pro-
gress in their disease trajectory. Younger patients and
more motivated patients, in particular, were more likely
to be included in a CT. Substantial regional differences
were observed, with Flemish GPs more likely to enrol
their diabetes patients on a CT.
The two most common reasons given by GPs for non-
inclusion were participation in another diabetes care
programme and the indication that inclusion would occur
in the near future.
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